Sector Charles River Laboratories International, Inc. Berne S.E.
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
End-of-day quote
Berne S.E.
2026-09-03
|
5-day change | 1st Jan Change | ||
| 233.98 CHF | +0.82% |
|
-3.43% | - |
| Aug. 20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| Aug. 20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -2.54% | -2.84% | +1.94% | +15.43% | +5.47% | -1.90% | +14.52% | -27.71% | +201.86% | 50.35B | |
| -1.00% | +0.50% | +7.99% | +34.18% | +162.28% | +436.35% | +520.09% | +578.72% | - | 45.2B | |
| -1.29% | +2.35% | +17.39% | +43.35% | +18.85% | +45.53% | +21.28% | +1.30% | +250.00% | 44.71B | |
| -0.88% | -2.18% | +11.07% | +28.16% | +18.09% | +12.56% | +75.14% | +3.51% | +1,105.02% | 41.24B | |
| +0.53% | -1.67% | +3.24% | +5.11% | +9.12% | +15.16% | +49.88% | -19.16% | +145.35% | 33.08B | |
| -1.21% | +7.94% | +9.41% | +22.28% | - | - | - | - | - | 17.81B | |
| +0.12% | -1.00% | +3.40% | +29.63% | +5.87% | +23.28% | +124.30% | +206.81% | +1,850.85% | 16.56B | |
| -1.01% | +0.50% | +5.67% | +11.81% | +16.54% | +15.83% | +27.98% | -41.39% | +92.30% | 14.82B | |
| -1.24% | -0.51% | +23.87% | +56.09% | +45.38% | +78.67% | +41.96% | -35.44% | +258.12% | 14B | |
| +0.70% | -2.72% | +5.44% | +8.24% | -9.24% | -6.22% | -36.06% | -36.76% | +120.14% | 12.62B | |
| -0.03% | +0.10% | +0.46% | +36.18% | +23.14% | +36.85% | -6.26% | -43.66% | +169.97% | 11.36B | |
| -0.36% | +0.70% | +37.07% | +23.40% | +9.21% | -17.45% | - | - | - | 11.67B | |
| -4.21% | -8.67% | +14.19% | +75.35% | +44.88% | +29.28% | +39.91% | -49.77% | - | 10.81B | |
| -1.56% | +0.21% | -10.21% | +16.26% | -18.94% | +34.07% | +453.29% | +194.42% | +2,370.89% | 10.78B | |
| +1.36% | -3.64% | +6.83% | -21.70% | -25.64% | -0.88% | +49.54% | +56.67% | +100.31% | 9.66B | |
| -13.33% | -11.33% | +93.01% | +134.43% | +153.30% | +81.43% | +71.16% | -12.00% | +1,200.00% | 10.13B | |
| -0.74% | +2.39% | +13.84% | +33.33% | +19.76% | +665.87% | +1,522.94% | +4.31% | - | 9.92B | |
| -0.27% | -1.05% | +11.99% | +56.69% | +50.25% | +177.04% | +487.49% | +84.87% | - | 9.75B | |
| -1.82% | +1.18% | +7.53% | +42.08% | +67.21% | +145.03% | +646.24% | +200.31% | +1,064.59% | 9.63B | |
| Average | -1.52% | -1.51% | +13.90% | +34.23% | +33.09% | +98.36% | +241.38% | +62.65% | +686.88% | 20.21B | |
| Weighted average by Cap. | -1.34% | -1.15% | +11.26% | +30.35% | +37.27% | +97.65% | +183.49% | +85.92% | +572.65% |
- Stock Market
- Stocks
- CRL Stock
- RV6 Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
